• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能 microRNA 筛选揭示 O-链接 N-乙酰葡萄糖胺转移酶作为一种宿主因子调节丙型肝炎病毒形态发生和感染力。

Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.

机构信息

Inserm, U1110, Institut de Recherche sur les Maladies Virales et Hépatiques, Strasbourg, France.

University of Strasbourg, Strasbourg, France.

出版信息

Gut. 2020 Feb;69(2):380-392. doi: 10.1136/gutjnl-2018-317423. Epub 2019 May 10.

DOI:10.1136/gutjnl-2018-317423
PMID:31076402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7613422/
Abstract

OBJECTIVE

Infection of human hepatocytes by the hepatitis C virus (HCV) is a multistep process involving both viral and host factors. microRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. Given that miRNAs were indicated to regulate between 30% and 75% of all human genes, we aimed to investigate the functional and regulatory role of miRNAs for the HCV life cycle.

DESIGN

To systematically reveal human miRNAs affecting the HCV life cycle, we performed a two-step functional high-throughput miRNA mimic screen in Huh7.5.1 cells infected with recombinant cell culture-derived HCV. miRNA targeting was then assessed using a combination of computational and functional approaches.

RESULTS

We uncovered miR-501-3p and miR-619-3p as novel modulators of HCV assembly/release. We discovered that these miRNAs regulate O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) protein expression and identified OGT and O-GlcNAcylation as regulators of HCV morphogenesis and infectivity. Furthermore, increased OGT expression in patient-derived liver tissue was associated with HCV-induced liver disease and cancer.

CONCLUSION

miR-501-3p and miR-619-3p and their target OGT are previously undiscovered regulatory host factors for HCV assembly and infectivity. In addition to its effect on HCV morphogenesis, OGT may play a role in HCV-induced liver disease and hepatocarcinogenesis.

摘要

目的

丙型肝炎病毒(HCV)感染人类肝细胞是一个多步骤的过程,涉及病毒和宿主因素。microRNAs(miRNAs)是一种小的非编码 RNA,可在后转录水平调节基因表达。鉴于 miRNAs 被认为可以调节人类所有基因的 30%至 75%,我们旨在研究 miRNAs 在 HCV 生命周期中的功能和调节作用。

设计

为了系统地揭示影响 HCV 生命周期的人类 miRNAs,我们在感染重组细胞培养衍生 HCV 的 Huh7.5.1 细胞中进行了两步功能性高通量 miRNA 模拟筛选。然后使用计算和功能方法的组合评估 miRNA 靶标。

结果

我们发现 miR-501-3p 和 miR-619-3p 是 HCV 组装/释放的新调节因子。我们发现这些 miRNA 调节 O-连接的 N-乙酰葡萄糖胺(O-GlcNAc)转移酶(OGT)蛋白表达,并确定 OGT 和 O-GlcNAc 化是 HCV 形态发生和感染性的调节剂。此外,患者来源的肝组织中 OGT 表达增加与 HCV 诱导的肝病和癌症有关。

结论

miR-501-3p 和 miR-619-3p 及其靶标 OGT 是 HCV 组装和感染性的先前未发现的调节宿主因子。除了对 HCV 形态发生的影响外,OGT 可能在 HCV 诱导的肝病和肝癌发生中起作用。

相似文献

1
Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.功能 microRNA 筛选揭示 O-链接 N-乙酰葡萄糖胺转移酶作为一种宿主因子调节丙型肝炎病毒形态发生和感染力。
Gut. 2020 Feb;69(2):380-392. doi: 10.1136/gutjnl-2018-317423. Epub 2019 May 10.
2
Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.丙型肝炎病毒诱导肝细胞中微小RNA miR-146a-5p上调,促进病毒感染并失调与肝病发病机制相关的代谢途径。
J Virol. 2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.
3
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.微小RNA-122通过与闭合蛋白(OCLN)信使核糖核酸(mRNA)的3'非翻译区(UTR)结合,减少丙型肝炎病毒(HCV)进入肝细胞。
Liver Int. 2015 Apr;35(4):1315-23. doi: 10.1111/liv.12698. Epub 2014 Oct 28.
4
MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors.MicroRNA-135a 通过下调宿主抗病毒因子来调节丙型肝炎病毒基因组复制。
Virol Sin. 2019 Apr;34(2):197-210. doi: 10.1007/s12250-018-0055-9. Epub 2018 Nov 19.
5
Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.丙型肝炎病毒诱导的外泌体 microRNAs 和 Toll 样受体 7 多态性调节 B 细胞激活因子。
mBio. 2021 Dec 21;12(6):e0276421. doi: 10.1128/mBio.02764-21. Epub 2021 Nov 2.
6
Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.丙型肝炎病毒诱导的 microRNA 107 (miRNA-107) 和 miRNA-449a 的变化通过靶向肝炎中的白细胞介素 6 受体复合物调节 CCL2。
J Virol. 2014 Apr;88(7):3733-43. doi: 10.1128/JVI.03060-13. Epub 2014 Jan 15.
7
MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?microRNA-155 和 microRNA-196b:丙型肝炎病毒感染有前途的生物标志物?
Rev Med Virol. 2014 May;24(3):169-85. doi: 10.1002/rmv.1785. Epub 2014 Mar 4.
8
Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.靶向 microRNA 治疗丙型肝炎病毒感染和肝脏病变:抑制病毒和改变宿主。
Pharmacol Res. 2013 Sep;75:48-59. doi: 10.1016/j.phrs.2013.03.004. Epub 2013 Mar 27.
9
Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.丙型肝炎病毒对 miR-181c 的转录抑制作用增强了同源盒 A1 的表达。
J Virol. 2014 Jul;88(14):7929-40. doi: 10.1128/JVI.00787-14. Epub 2014 Apr 30.
10
Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.丙型肝炎病毒介导的微小RNA miR-373增强会损害JAK/STAT信号通路。
J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

引用本文的文献

1
O-GlcNAc transferase plays dual antiviral roles by integrating innate immunity and lipid metabolism.O-连接的N-乙酰葡糖胺转移酶通过整合先天免疫和脂质代谢发挥双重抗病毒作用。
Nat Commun. 2025 Aug 19;16(1):7721. doi: 10.1038/s41467-025-63085-y.
2
Protein O-GlcNAcylation in reproductive biology and the impact of metabolic disease.生殖生物学中的蛋白质O-连接N-乙酰葡糖胺化修饰以及代谢性疾病的影响
Hum Reprod Update. 2025 Jun 26. doi: 10.1093/humupd/dmaf013.
3
O-glycosylation in viruses: A sweet tango.病毒中的O-糖基化:一场甜蜜的探戈。
mLife. 2024 Mar 25;3(1):57-73. doi: 10.1002/mlf2.12105. eCollection 2024 Mar.
4
Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases.O-糖基化在肝细胞应激和肝脏疾病中的生物学功能及潜在治疗意义。
Cells. 2024 May 9;13(10):805. doi: 10.3390/cells13100805.
5
Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.生物钟、代谢和细胞信号对蛋白质 O-GlcNAcylation 的调节。
J Biol Chem. 2024 Feb;300(2):105616. doi: 10.1016/j.jbc.2023.105616. Epub 2023 Dec 29.
6
Decreased miR-329-3p upregulates and in mouse hepatic I/R injury in an age-independent manner.miR-329-3p 表达下调通过调控 和 的表达促进小鼠肝缺血再灌注损伤
Int J Med Sci. 2023 Sep 18;20(12):1562-1569. doi: 10.7150/ijms.87174. eCollection 2023.
7
Integrated Analysis of Gut Microbiome and Liver Metabolome to Evaluate the Effects of Fecal Microbiota Transplantation on Lipopolysaccharide/D-galactosamine-Induced Acute Liver Injury in Mice.基于肠道微生物组和肝脏代谢组学的综合分析评估粪菌移植对脂多糖/半乳糖胺诱导的小鼠急性肝损伤的影响。
Nutrients. 2023 Feb 24;15(5):1149. doi: 10.3390/nu15051149.
8
The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions.糖基化与非编码 RNA 在癌症及其他生理病理条件下的相互关系。
Int J Mol Sci. 2022 Dec 13;23(24):15804. doi: 10.3390/ijms232415804.
9
Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer.溶瘤腺病毒,一种前列腺癌的新治疗策略。
Biomedicines. 2022 Dec 15;10(12):3262. doi: 10.3390/biomedicines10123262.
10
Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis.miRNAs 在丙型肝炎病毒复制和发病机制中的作用。
Viruses. 2022 Aug 15;14(8):1776. doi: 10.3390/v14081776.

本文引用的文献

1
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.糖基掩蔽与丙型肝炎病毒中和抗体的调节。
Front Immunol. 2018 Apr 27;9:910. doi: 10.3389/fimmu.2018.00910. eCollection 2018.
2
Cellular microRNA networks regulate host dependency of hepatitis C virus infection.细胞 microRNA 网络调控丙型肝炎病毒感染的宿主依赖性。
Nat Commun. 2017 Nov 27;8(1):1789. doi: 10.1038/s41467-017-01954-x.
3
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.慢性丙型肝炎病毒感染者直接抗病毒治疗后耐药相关替代的模式。
Gastroenterology. 2018 Mar;154(4):976-988.e4. doi: 10.1053/j.gastro.2017.11.007. Epub 2017 Nov 13.
4
Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.人嗜T淋巴细胞病毒1型(HTLV-1)的Tax癌蛋白劫持O-GlcNAcZYME复合物可促进病毒转录。
PLoS Pathog. 2017 Jul 24;13(7):e1006518. doi: 10.1371/journal.ppat.1006518. eCollection 2017 Jul.
5
Protein O-GlcNAcylation: emerging mechanisms and functions.蛋白质O-连接的N-乙酰葡糖胺糖基化:新出现的机制与功能
Nat Rev Mol Cell Biol. 2017 Jul;18(7):452-465. doi: 10.1038/nrm.2017.22. Epub 2017 May 10.
6
Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver.丙型肝炎病毒感染和干扰素-α治疗在人类肝脏中的转录反应。
EMBO Mol Med. 2017 Jun;9(6):816-834. doi: 10.15252/emmm.201607006.
7
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.O-GlcNAc 转移酶通过诱导棕榈酸和激活内质网应激促进脂肪性肝病相关肝癌。
J Hepatol. 2017 Aug;67(2):310-320. doi: 10.1016/j.jhep.2017.03.017. Epub 2017 Mar 25.
8
Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.新一代抗病毒药物时代的丙型肝炎相关肝细胞癌
BMC Med. 2017 Mar 14;15(1):52. doi: 10.1186/s12916-017-0815-7.
9
miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.miR-135a-5p 介导的蛋白酪氨酸磷酸酶受体 delta 下调是 HCV 相关肝癌发生的候选驱动因素。
Gut. 2018 May;67(5):953-962. doi: 10.1136/gutjnl-2016-312270. Epub 2017 Feb 3.
10
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.RG-101 治疗慢性丙型肝炎患者的安全性、耐受性和抗病毒效果:一项 1B 期、双盲、随机对照试验。
Lancet. 2017 Feb 18;389(10070):709-717. doi: 10.1016/S0140-6736(16)31715-9. Epub 2017 Jan 11.